Ksilink and Anagenesis Biotechnologies

Ksilink and Anagenesis Biotechnologies

On February 2nd 2016, Ksilink and Anagenesis Biotechnologies announce a collaborative research agreement to apply stem-cell derived disease models of Duchenne Muscular Dystrophy to small molecule therapies discovery and development.   Download the press release in...
Mr Jean-Yves Le Déaut visits Ksilink

Mr Jean-Yves Le Déaut visits Ksilink

On January 26th 2016, Mr Jean-Yves Le Déaut, French Deputy and President of Office parlementaire d’évaluation des choix scientifiques et technologiques (OPECST) visited Ksilink. Mr Le Déaut was welcomed by Professor André Syrota, President of Ksilink and Dr Ulf...